Prostaglandin E2 contributes to <i>L. braziliensis</i> survival and therapeutic failure in cutaneous leishmaniasis-Reference-Cited by-同舟云学术

Prostaglandin E2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis

Published:2023-09-28 Issue:2 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Nascimento Maurício T.¹²³^ORCID,Viana Débora L.¹^ORCID,Peixoto Fábio C.¹³^ORCID,Arruda Sérgio M.⁴^ORCID,Carvalho Edgar M.¹²³⁵^ORCID,Carvalho Lucas P.¹²³⁵^ORCID

Affiliation:

1. Laboratório de Pesquisas Clínicas, LAPEC, Instituto Gonçalo Moniz – Fiocruz, Salvador, Brazil

2. Serviço de Imunologia, SIM, Complexo Universitário Professor Edgar Santos, COM-HUPES, Salvador, Brazil

3. Programa de Pós-Graduação em Ciências da Saúde, PPgCS, Universidade Federal da Bahia, Salvador, Brazil

4. Laboratório Avançado de Saúde Pública, LASP, Instituto Gonçalo Moniz – Fiocruz, Salvador, Brazil

5. Instituto de Ciência e Tecnologia em Doenças Tropicais, INCT-DT, Salvador, Brazil

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2023.2261565

Reference39 articles.

1. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis

2. WHO. Expert Committee on the Control of the Leishmaniases & World Health Organization. Control of the leishmaniases: report of a meeting of the WHO Expert Commitee on the Control of Leishmaniases. World Health Organization. Geneva 22–26 March 2010.

3. Epidemiological and Clinical Changes in American Tegumentary Leishmaniasis in an Area of Leishmania (Viannia) braziliensis Transmission Over a 20-Year Period

4. Association of Treatment of American Cutaneous Leishmaniasis Prior to Ulcer Development with High Rate of Failure in Northeastern Brazil

5. Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial